当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3498203
自主品牌
已选条件
-
T77456Lumiliximab；鲁昔单抗IDEC-152|||ST-152；IDEC-152|||ST-152
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.
价 格：￥电议型 号：T77456产 地：中国大陆
-
T77455Burosumab；布洛舒单抗KRN23；KRN23
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
价 格：￥电议型 号：T77455产 地：中国大陆
-
T77450Vantictumab；化合物 vantictumabOMP-18R5；OMP-18R5
Vantictumab (OMP-18R5), a fully human IgG2 monoclonal antibody, antagonizes Wnt pathway signaling through binding to FZD1/2/5/7/8 receptors. It is currently under investigation for the treatment of various cancers, including metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma [1] [2].
价 格：￥电议型 号：T77450产 地：中国大陆
-
T77448Naxitamab；那昔妥单抗Naxitamab-gqgk|||Humanized 3F8|||Hu3F8；Naxitamab-gqgk|||Humanized 3F8|||Hu3F8
Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
价 格：￥电议型 号：T77448产 地：中国大陆
-
T77443Racotumomab；雷妥莫单抗Racotumomab
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody. It can specifically induce an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), which is overexpressed in a variety of solid tumors. Racotumomab reacts with gangliosides containing NU-Glycolyl (NeuGc), thioglycosides, and other antigens expressed in tumors. Racotumomab has anti-cancer activity and can be used in the study of lung cancer.
价 格：￥电议型 号：T77443产 地：中国大陆
-
T77442Glenzocimab；格仑西单抗ACT017；ACT017
Glenzocimab (ACT017) is a Fab fragment of a humanized anti-GPVI monoclonal antibody. Glenzocimab demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model. Glenzocimab has been studied in acute ischemic stroke and cerebral thrombosis.
价 格：￥电议型 号：T77442产 地：中国大陆
-
T77440Codrituzumab；考曲妥珠单抗RG-7686|||RO5137382|||GC33；RG-7686|||RO5137382|||GC33
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
价 格：￥电议型 号：T77440产 地：中国大陆
-
T77439Glembatumumab；格巴妥木单抗Glembatumumab
Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma.Glembatumumab is a naked antibody to Glembatumumab vedotin and can be used to study antibody-activated molecule couplings (Glembatumumab vedotin ).
价 格：￥电议型 号：T77439产 地：中国大陆
-
T77437Telisotuzumab；特立妥珠单抗ABT-700|||Mab-224G11；ABT-700|||Mab-224G11
Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.
价 格：￥电议型 号：T77437产 地：中国大陆
-
T77434Vopratelimab；伏派利单抗JTX 2011；JTX 2011
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody that is a potent ICOS agonist. Vopratelimab has a high affinity for inducible T cell CO stimulating factors (ICOS), with an affinity of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS. Vopratelimab has an anti-tumor immune effect and can be used to improve metastatic non-small cell lung cancer.
价 格：￥电议型 号：T77434产 地：中国大陆
-
T77433Feladilimab；菲阿迪利单抗GSK3359609；GSK3359609
Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNγ, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.
价 格：￥电议型 号：T77433产 地：中国大陆
-
T77432Anifrolumab；阿尼鲁单抗MDX-1333|||MEDI-546；MDX-1333|||MEDI-546
Anifrolumab（MEDI-546） is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).
价 格：￥电议型 号：T77432产 地：中国大陆
-
T77426Pascolizumab；帕考珠单抗SB-240683；SB-240683
Pascolizumab (SB-240683) is a humanized monoclonal antibody against IL-4. Pascolizumab has asthmatic effects and can be used to study allergic rhinitis.
价 格：￥电议型 号：T77426产 地：中国大陆
-
T77423Lirilumab；利瑞鲁单抗ONO-4483|||IPH2102；ONO-4483|||IPH2102
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN).
价 格：￥电议型 号：T77423产 地：中国大陆
-
T77422Lacutamab；拉可妥单抗IPH 41|||IPH 4102；IPH 41|||IPH 4102
Lacutamab (IPH 4102) is a potent and selective humanized anti-KIR3DL2 antibody.Lacutamab has potential anticancer activity for the study of leukemia and lymphoma.
价 格：￥电议型 号：T77422产 地：中国大陆
-
T77416Opicinumab；奥匹努单抗BIIB033；BIIB033
Opicinumab (BIIB033) is a novel monoclonal antibody against LINGO-1 that may be used to prevent and delay acute optic neuritis and recurrent multiple sclerosis.
价 格：￥电议型 号：T77416产 地：中国大陆
-
T77415Ladiratuzumab纬拉妥珠单hLIV22
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.LadiratuzumAb can be used for the prevention and treatment of breast cancer.
价 格：￥电议型 号：T77415产 地：中国大陆
-
T77412Lupartumab；鲁帕妥单抗BAY 1112623；BAY 1112623
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used to synthesize antibody-active molecular couplers that can be used to study LYPD3-associated tumor diseases.
价 格：￥电议型 号：T77412产 地：中国大陆
-
T77408Abagovomab阿巴伏单抗ACA 125
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal antibody that targets the tumor-associated antigen CA-125. Abagovomab is produced by hybridoma cells in mice. Abagovomab can be used to study ovarian cancer.
价 格：￥电议型 号：T77408产 地：中国大陆
-
T77407Ensituximab；恩妥昔单抗NPC-1C|||NEO-102|||NEO-101；NPC-1C|||NEO-102|||NEO-101
Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.
价 格：￥电议型 号：T77407产 地：中国大陆
